TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial

Deepa Joshi1 Torrent Pharmaceuticals Ltd., Ahmedabad, Gujarat, IndiaCorrespondence[email protected]
View further author information

Prashant GJ1 Torrent Pharmaceuticals Ltd., Ahmedabad, Gujarat, IndiaView further author information

Shohini Ghosh1 Torrent Pharmaceuticals Ltd., Ahmedabad, Gujarat, IndiaView further author information

Anookh Mohanan1 Torrent Pharmaceuticals Ltd., Ahmedabad, Gujarat, IndiaView further author information

Viswanathan Mohan3 Dr. Mohan’s Diabetes Specialities Centre (Madras Diabetes Research Foundation), Tamil Nadu, India

Subhankar Chowdhury4 Department of Endocrinology, Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital, Kolkata, IndiaView further author information

Chaitanya Dutt1 Torrent Pharmaceuticals Ltd., Ahmedabad, Gujarat, IndiaView further author information

Nikhil Tandon5 Department of Endocrinology, All India Institute of Medical Sciences, New Delhi, IndiaView further author information

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.